Literature DB >> 1079685

Metabolism of metoprolol-(3-h) in man, the dog and the rat.

K O Borg, E Carlsson, K J Hoffmann, T E Jönsson, H Thorin, B Wallin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1079685     DOI： 10.1111/j.1600-0773.1975.tb03329.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  42 in total

1.  Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors:  G Johnsson; C G Regårdh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Lack of effect of omeprazole treatment on steady-state plasma levels of metoprolol.

Authors:  T Andersson; P Lundborg; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype.

Authors:  Nitin Kaila; Robert J Straka; Richard C Brundage
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

4.  Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2.

Authors:  N Bodor; Y Oshiro; T Loftsson; M Katovich; W Caldwell
Journal:  Pharm Res       Date:  1984-05       Impact factor: 4.200

Review 5.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

6.  Plasma metoprolol concentrations in young, old and hypertensive subjects.

Authors:  M J Kendall; D Brown; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

7.  Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failure.

Authors:  A Bortolotti; D Castelli; D Verotta; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Apr-Jun       Impact factor: 2.441

8.  Polymorphic metabolism of metoprolol: clinical studies.

Authors:  J H Silas; J C McGourty; M S Lennard; G T Tucker; H F Woods
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.

Authors:  J C McGourty; J H Silas; M S Lennard; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 10.  CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis.

Authors:  Maxime Meloche; Michael Khazaka; Imad Kassem; Amina Barhdadi; Marie-Pierre Dubé; Simon de Denus
Journal:  Br J Clin Pharmacol       Date:  2020-04-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.